Audrey K Alvarez, DPM
Podiatry · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 4 carriers
- Office
- 1
- Since medical school
- 9 years
- California School of Podiatric Medicine, 2017
Offices
1 location · Bay Area Foot Care Inc · 127 clinicians in this group
Hospitals listed: 059551 · Eden Medical Center · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alvarez’s office at (510) 581-1484 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$265,436
Medicare paid this office $265,436 for 339 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 154 | $29,257 | $86 |
| Removal of skin and tissue, 20.0 sq cm or less | 41 | $24,599 | $137 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 43 | $22,908 | $104 |
| Return visit (30+ min) | 93 | $22,750 | $128 |
| Removal of noncancer thickened skin growth, 2-4 growths | 71 | $16,480 | $83 |
See all 21 services
| Short return visit (20+ min) | 154 | $29,257 | $86 |
| Removal of skin and tissue, 20.0 sq cm or less | 41 | $24,599 | $137 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 43 | $22,908 | $104 |
| Return visit (30+ min) | 93 | $22,750 | $128 |
| Removal of noncancer thickened skin growth, 2-4 growths | 71 | $16,480 | $83 |
| Removal of fingernails or toenails, 6 or more nails | 115 | $11,131 | $43 |
| Removal of fingernails or toenails, 1-5 nails | 94 | $7,518 | $32 |
| Removal of noncancer thickened skin growth, 1 growth | 52 | $7,441 | $66 |
| Test or measurement for functional capacity, each 15 minutes | 100 | $6,245 | $31 |
| Removal of noncancer thickened skin growth, more than 4 growths | 22 | $5,163 | $88 |
| Detection test by nucleic acid for organism, amplified probe technique | 11 | $4,918 | $34 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $4,602 | $124 |
| New patient visit (45+ min) | 28 | $4,412 | $158 |
| Trimming of dystrophic nails, any number | 86 | $3,962 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,774 | $75 |
| X-ray of foot, minimum of 3 views | 45 | $3,328 | $38 |
| Long return visit (40+ min) | 14 | $2,635 | $176 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 12 | $447 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 11 | $413 | $34 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 11 | $413 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 11 | $378 | $34 |
Procedures Medicare counted
| Removal of nail tissue | 716 | More than 88% of doctors who do this |
| Removal of tissue | 211 | More than 92% of doctors who do this |
| Removal or shaving of skin growth | 344 | More than 93% of doctors who do this |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Removal of fingernails or toenails, 6 or more nails | 51 | 285 | 196 | 261 |
| Removal of fingernails or toenails, 1-5 nails | 150 | 171 | 174 | 235 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 82 | 292 | 116 | 220 |
| Removal of noncancer thickened skin growth, 2-4 growths | 62 | 143 | 131 | 199 |
| Removal of skin and tissue, 20.0 sq cm or less | 35 | 172 | 122 | 180 |
| Removal of noncancer thickened skin growth, 1 growth | 42 | 67 | 90 | 112 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
339 Original Medicare patients in 2024. Average age 75 · Under 65 13% · 85 and older 19% · Women 51% · Also on Medicaid 36% · Health risk score 2.40. Sicker patients than 9 in 10 peers; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 57% · Chronic kidney disease 47% · Coronary heart disease 36% · Heart failure 32% · Atrial fibrillation 24% · Depression 22% · COPD 18% · Cancer 13% · Dementia 13% · Stroke 13%.
The office billed $950,228, Medicare allowed $339,750 and paid $265,436; for 2,930 services of 74 kinds; $46,119 of it was for drugs given in the office and $219,317 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 339 | 2,930 | 75 | 2.40 | $950,228 | $265,436 |
| 2023 | 312 | 1,895 | 74 | 1.98 | $761,544 | $202,244 |
| 2022 | 347 | 3,445 | 75 | 2.16 | $1,060,911 | $334,990 |
| 2021 | 256 | 1,153 | 74 | 1.94 | $250,257 | $92,962 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Short return visit (20+ min) | 160 | $24,976 | $82 |
| Removal of skin and tissue, 20.0 sq cm or less | 36 | $13,428 | $110 |
| Removal of noncancer thickened skin growth, 2-4 growths | 63 | $10,578 | $81 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 32 | $9,703 | $84 |
| Removal of fingernails or toenails, 6 or more nails | 97 | $8,075 | $41 |
| Removal of noncancer thickened skin growth, 1 growth | 50 | $6,364 | $71 |
| Return visit (30+ min) | 28 | $5,675 | $118 |
| Removal of noncancer thickened skin growth, more than 4 growths | 27 | $5,627 | $89 |
| Removal of fingernails or toenails, 1-5 nails | 74 | $5,518 | $32 |
| Trimming of dystrophic nails, any number | 81 | $3,167 | $17 |
| New patient visit (30+ min) | 22 | $2,000 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,725 | $115 |
| New patient visit (45+ min) | 12 | $1,706 | $142 |
| X-ray of foot, minimum of 3 views | 27 | $1,292 | $34 |
| Test or measurement for functional capacity, each 15 minutes | 21 | $1,065 | $27 |
2022: 17 services
| Short return visit (20+ min) | 208 | $35,979 | $79 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 43 | $26,573 | $91 |
| Return visit (30+ min) | 84 | $23,028 | $115 |
| Removal of skin and tissue, 20.0 sq cm or less | 53 | $20,659 | $120 |
| Removal of fingernails or toenails, 6 or more nails | 128 | $11,574 | $41 |
| Removal of noncancer thickened skin growth, more than 4 growths | 48 | $11,262 | $84 |
| Removal of noncancer thickened skin growth, 2-4 growths | 61 | $11,247 | $79 |
| Strapping, unna boot | 39 | $11,177 | $70 |
| New patient visit (45+ min) | 61 | $8,281 | $136 |
| Removal of fingernails or toenails, 1-5 nails | 80 | $4,971 | $29 |
| Removal of noncancer thickened skin growth, 1 growth | 40 | $4,368 | $65 |
| Trimming of dystrophic nails, any number | 81 | $2,984 | $16 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 11 | $2,968 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,878 | $111 |
| New patient visit (30+ min) | 21 | $1,752 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,385 | $53 |
| X-ray of foot, minimum of 3 views | 25 | $1,219 | $36 |
2021: 14 services
| Short return visit (20+ min) | 102 | $12,902 | $83 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 17 | $9,149 | $112 |
| Return visit (30+ min) | 36 | $7,931 | $118 |
| New patient visit (45+ min) | 45 | $6,460 | $144 |
| Removal of noncancer thickened skin growth, 2-4 growths | 33 | $4,798 | $77 |
| Removal of fingernails or toenails, 1-5 nails | 82 | $4,701 | $31 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $4,127 | $118 |
| Trimming of dystrophic nails, any number | 101 | $3,650 | $20 |
| New patient visit (30+ min) | 35 | $3,440 | $98 |
| Removal of noncancer thickened skin growth, 1 growth | 31 | $2,741 | $65 |
| Removal of fingernails or toenails, 6 or more nails | 32 | $2,153 | $42 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $2,000 | $118 |
| Removal of noncancer thickened skin growth, more than 4 growths | 15 | $1,702 | $85 |
| X-ray of foot, minimum of 3 views | 24 | $851 | $32 |
Medicaid work
$5,870 in 2024
Medicaid paid $5,870 for 232 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 139 | $3,954 |
| Application of multi-layer compression system; leg (below knee), including ankle and foot | 72 | $1,371 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 21 | $545 |
| 2024 | 232 | 3 | 19 | $5,870 |
| 2022 | 14 | 1 | 14 | $50 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 14 | $50 |
Drugs they prescribed that Part D paid
$23,185
Pharmacies billed $23,185 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 12% of their Part D prescriptions (37 of 312) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
288 generic and 24 brand-name prescriptions · $23,185 in drug cost · 82 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 44 | $1,423 | $32 |
| Gabapentin | 39 | $561 | $14 |
| Hydrocodone-Acetaminophen | 17 | $236 | $14 |
| Doxycycline Hyclate | 16 | $215 | $13 |
| Amoxicillin-Clavulanate Potass | 17 | $174 | $10 |
See all 8 drugs
| Ketoconazole | 44 | $1,423 | $32 |
| Gabapentin | 39 | $561 | $14 |
| Hydrocodone-Acetaminophen | 17 | $236 | $14 |
| Doxycycline Hyclate | 16 | $215 | $13 |
| Amoxicillin-Clavulanate Potass | 17 | $174 | $10 |
| Ciprofloxacin | 17 | $93 | $5 |
| Triamcinolone Acetonide | 13 | $59 | $5 |
| Sulfamethoxazole-Trimethoprim | 13 | $52 | $4 |
Year by year
| 2024 | 312 | 116 | 12% (37) | 8% | $23,185 |
| 2023 | 256 | 97 | 6% (15) | 6% | $15,581 |
| 2022 | 400 | 128 | 11% (45) | 4% | $14,902 |
| 2021 | 164 | 72 | None | None | $4,790 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Gabapentin | 83 | $1,540 | $19 |
| Ketoconazole | 12 | $439 | $37 |
| Amoxicillin-Clavulanate Potass | 16 | $132 | $8 |
| Cephalexin | 14 | $96 | $7 |
2022: 8 drugs
| Ketoconazole | 60 | $2,210 | $37 |
| Gabapentin | 114 | $1,832 | $16 |
| Oxycodone-Acetaminophen | 18 | $342 | $19 |
| Cephalexin | 31 | $289 | $9 |
| Hydrocodone-Acetaminophen | 19 | $210 | $11 |
| Amoxicillin-Clavulanate Potass | 18 | $206 | $11 |
| Doxycycline Hyclate | 15 | $203 | $14 |
| Sulfamethoxazole-Trimethoprim | 21 | $119 | $6 |
2021: 3 drugs
| Ketoconazole | 23 | $841 | $37 |
| Gabapentin | 51 | $484 | $9 |
| Cephalexin | 13 | $108 | $8 |
Money from drug and device companies
$864 in 2025
| 2025 | 11 | 23 | None | $864 |
| 2024 | 10 | 25 | None | $1,109 |
| 2023 | 4 | 10 | None | $503 |
| 2022 | 6 | 18 | None | $625 |
| 2021 | 5 | 11 | None | $193 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Treace Medical Concepts | Tmc Nanoplasty System | $187 | 4 payments
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $150 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $138 | 6 payments
|
| Amgen | Krystexxa | $122 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $55 | 2 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $52 | 2 payments
|
See all 23 published payments
| Treace Medical Concepts | Meals · 2025-12-08 | Tmc Nanoplasty System | $4 |
| Bioventus | Meals · 2025-12-05 | Exogen Ultrasound Bone Healing System | $31 |
| Smith+Nephew | Meals · 2025-11-21 | Collagenase Santyl | $8 |
| Orthofix Medical | Meals · 2025-11-14 | Physio-Stim | $18 |
| Treace Medical Concepts | Meals · 2025-10-23 | Tmc Nanoplasty System | $16 |
| Smith+Nephew | Meals · 2025-10-17 | Collagenase Santyl | $33 |
| Bioventus | Meals · 2025-09-12 | Exogen Ultrasound Bone Healing System | $21 |
| Treace Medical Concepts | Meals · 2025-08-27 | Tmc Nanoplasty System | $31 |
| Treace Medical Concepts | Meals · 2025-08-20 | Tmc Nanoplasty System | $136 |
| Paratek Pharmaceuticals | Meals · 2025-08-07 | Nuzyra | $32 |
| DePuy Synthes Sales | Meals · 2025-08-06 | Motoband | $25 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-08-04 | Jublia | $21 |
| Amgen | Meals · 2025-07-31 | Krystexxa | $122 |
| Smith+Nephew | Meals · 2025-07-24 | Collagenase Santyl | $22 |
| DePuy Synthes Sales | Meals · 2025-05-23 | Motoband | $27 |
| Smith+Nephew | Meals · 2025-04-25 | Collagenase Santyl | $8 |
| Urgo Medical North America | Meals · 2025-03-28 | Urgok2 | $19 |
| Ermi | Meals · 2025-02-26 | None | $22 |
| Paratek Pharmaceuticals | Meals · 2025-02-13 | Nuzyra | $23 |
| Smith+Nephew | Meals · 2025-01-31 | Collagenase Santyl | $45 |
| Urgo Medical North America | Meals · 2025-01-19 | Urgok2 | $30 |
| Smith+Nephew | Meals · 2025-01-15 | Collagenase Santyl | $21 |
| Curonix | Meals · 2025-01-09 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $150 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,109
| Smith+Nephew | Pico | $311 | 13 payments
|
| Stryker | Infinity | $297 | 2 payments
|
| Alafair Biosciences | Versawrap | $177 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $176 | 2 payments
|
| Urgo Medical North America | Urgok2 | $28 | 1 payment
|
| Biotissue Holdings | None | $26 | 1 payment
|
| Paragon 28 | Precision Guide Lapidus | $26 | 1 payment
|
| Orthofix Medical | Physio-Stim | $26 | 1 payment
|
| Integra LifeSciences | Integra | $24 | 1 payment
|
| DePuy Synthes Sales | None | $17 | 1 payment
|
2023: $503
| Smith+Nephew | Collagenase Santyl | $250 | 7 payments
|
| Nevro | Senza | $130 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $96 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System | $27 | 1 payment
|
2022: $625
| Treace Medical Concepts | Lapiplasty System | $229 | 6 payments
|
| Smith+Nephew | Collagenase Santyl | $209 | 8 payments
|
| Melinta Therapeutics | Kimyrsa | $93 | 1 payment
|
| Nevro | Omnia | $35 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $31 | 1 payment
|
| Hartmann USA | Zetuvit Plus | $29 | 1 payment
|
2021: $193
| Smith+Nephew | Collagenase Santyl | $77 | 4 payments
|
| AbbVie | Dalvance | $57 | 3 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $26 | 1 payment
|
| Orthofix Medical | Physio-Stim | $20 | 1 payment
|
| Forte Bio-Pharma | Nalocet | $13 | 1 payment
|
Checkups this office reported
11 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 91.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 92%That's most of the people this applied to. | 406 |
| Checked for fall riskOlder patients screened for fall risk | 20%That's few of the people this applied to. | 284 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 40% | 53 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 90%That's most of the people this applied to. Worse on this measure. | 130 |
| Medications listed in the chartVisits where the current medication list was documented | 83%That's most of the people this applied to. | 1,236 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 69%That's more than half. | 708 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 98%That's most of the people this applied to. | 259 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 295 |
See the other 3 measures
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 1% | 1,161 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 81%That's most of the people this applied to. | 146 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 46%That's less than half. | 581 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Measurement and improvement at the practice and panel level
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from immunization registry reporting
Professional record
- NPI
- 1467973230
- Licence
- CA E5714
- Trained
- California School of Podiatric Medicine, 2017 · 9 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X); Student in a training program (390200000X)
- Mailing address
- 15045 5th Ave Sw #404, Burien, WA, 98166
- NPI first listed
- 2017-07-03
- NPI last updated
- 2022-06-26
- NPI record certified
- 2022-06-26
This is when the NPI record was last certified, not a medical board exam.